PPIDT00096
Drug Information
| Name | Vancomycin |
|---|---|
| Sequence | Not Available |
| DrugBank_ID | DB00512 |
| Type | small molecule |
| Indication | Administered intravenously, vancomycin is indicated in adult and pediatric patients for the treatment of septicemia, infective endocarditis, skin and skin structure infections, bone infections, and lower respiratory tract infections.[L41529] Administered orally, vancomycin is indicated in adult and pediatric patients for the treatment of _Clostridium difficile_-associated diarrhea and for enterocolitis caused by _Staphylococcus aureus_ (including methicillin-resistant strains).[L41534] |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Solution | Intravenous |
500.000 mg
|
| Injection, powder, for solution | Oral |
|
| Powder | Ophthalmic |
40.0 mg
|
| Injection | Intravenous |
1 g
|
| Injection | Intravenous |
|
| Injection | Intravenous |
500 mg
|
| Solution | Parenteral |
500 mg
|
| Solution | Parenteral |
500.000 mg
|
| Kit; powder, for solution | Oral |
|
| Kit; powder, for solution | Oral |
1 g/1g
|
| Powder | Oral |
1 G
|
| Powder, for solution | Oral |
500 MG
|
| Solution | Intravenous |
1.025 g
|
| Powder, for solution | Oral |
1 G
|
| Solution | Intravenous |
500.0 mg
|
| Capsule | Oral |
125 mg
|
| Capsule | Oral |
250 mg
|
| Powder, for solution | Intravenous |
5 g / vial
|
| Powder, for solution | Intravenous |
1 g / vial
|
| Powder, for solution | Intravenous |
500 mg / vial
|
| Injection, powder, lyophilized, for solution | Intravenous |
5 g/100mL
|
| Injection, powder, lyophilized, for solution | Intravenous |
500 mg/10mL
|
| Injection, powder, lyophilized, for solution | Intravenous |
51257100 mg
|
| Solution | Parenteral |
500.00 mg
|
| Solution | Parenteral |
512.6 mg
|
| Solution | Intravenous |
500.00 mg
|
| Powder | — |
1 GM
|
| Powder | — |
500 mg
|
| Solution | Parenteral |
1 mg
|
| Injection, powder, for solution | — |
500 mg
|
| Powder, for solution | Oral |
|
| Capsule | Oral |
125 mg/1
|
| Capsule | Oral |
250 mg/1
|
| Injection, powder, for solution | Intravenous |
500 mg
|
| Injection, powder, for solution | Intravenous |
50000000 mg
|
| Solution | Oral |
1 g
|
| Capsule | Oral |
|
| Solution | Oral |
500 mg
|
| Powder | Intravenous |
1 g / vial
|
| Powder, for solution | — |
1 G
|
| Powder, for solution | Intravenous; Oral |
500 mg
|
| Injection, powder, for solution | — |
|
| Injection, powder, lyophilized, for solution | Parenteral |
50000000 mg
|
| Injection, powder, lyophilized, for solution | Intravenous |
100000000 mg
|
| Injection, powder, lyophilized, for solution | Intravenous |
50000000 mg
|
| Injection, powder, lyophilized, for solution | Intravenous; Parenteral |
50000000 mg
|
| Powder, for solution | Oral; Parenteral |
1 G
|
| Powder, for solution | — |
|
| Injection, powder, for solution | Intravenous; Oral |
1 g
|
| Injection, powder, for solution | Intravenous; Oral |
500 mg
|
| Powder, for solution | Parenteral |
500 MG
|
| Powder, for solution | Intravenous |
|
| Injection, powder, lyophilized, for solution | Intravenous |
100000 g
|
| Injection, solution | Intravenous |
1.25 g/250mL
|
| Injection, solution | Intravenous |
1.5 g/300mL
|
| Injection, solution | Intravenous |
1.75 g/350mL
|
| Injection, solution | Intravenous |
2 g/400mL
|
| Injection, solution | Intravenous |
5 g/100mL
|
| Solution | Oral |
1000 mg
|
| Injection, solution | Intravenous |
4.2 mg/1mL
|
| Injection, solution | Intravenous |
5 mg/1mL
|
| Injection, solution | Intravenous |
6 mg/1mL
|
| Injection, powder, for solution | Parenteral |
1000 mg
|
| Injection, powder, for solution | Parenteral |
500 mg
|
| Injection | Intravenous |
10 g/100mL
|
| Injection | Intravenous |
5 g/100mL
|
| Injection, powder, for solution | — |
513 mg
|
| Injection, powder, for solution | Intravenous |
1 g/1
|
| Injection, powder, for solution | Intravenous |
10 g/1
|
| Injection, powder, for solution | Intravenous |
5 g/1
|
| Injection, powder, for solution | Intravenous |
500 mg/1
|
| Injection, powder, for solution | Intravenous; Oral |
10.25 g/1g
|
| Injection, powder, for solution | Intravenous; Oral |
1025 mg/1mg
|
| Injection, powder, for solution | Intravenous; Oral |
5.13 g/1g
|
| Injection, powder, for solution | Intravenous; Oral |
513 mg/1mg
|
| Injection, powder, lyophilized, for solution | Intravenous |
1 g/20mL
|
| Injection, powder, lyophilized, for solution | Intravenous |
1 g/1
|
| Injection, powder, lyophilized, for solution | Intravenous |
1 g/10mL
|
| Injection, powder, lyophilized, for solution | Intravenous |
1 g/250mL
|
| Injection, powder, lyophilized, for solution | Intravenous |
1 g/8mL
|
| Injection, powder, lyophilized, for solution | Intravenous |
1.25 g/25mL
|
| Injection, powder, lyophilized, for solution | Intravenous |
1.25 g/1
|
| Injection, powder, lyophilized, for solution | Intravenous |
1.5 g/1
|
| Injection, powder, lyophilized, for solution | Intravenous |
1.5 g/30mL
|
| Injection, powder, lyophilized, for solution | Intravenous |
1.75 g/35mL
|
| Injection, powder, lyophilized, for solution | Intravenous |
10 g/1
|
| Injection, powder, lyophilized, for solution | Intravenous |
10 g/100mL
|
| Injection, powder, lyophilized, for solution | Intravenous |
10 g/95mL
|
| Injection, powder, lyophilized, for solution | Intravenous |
100 mg/1mL
|
| Injection, powder, lyophilized, for solution | Intravenous |
100 g/1
|
| Injection, powder, lyophilized, for solution | Intravenous |
2 g/40mL
|
| Injection, powder, lyophilized, for solution | Intravenous |
250 mg/5mL
|
| Injection, powder, lyophilized, for solution | Intravenous |
5 g/1
|
| Injection, powder, lyophilized, for solution | Intravenous |
500 mg/4mL
|
| Injection, powder, lyophilized, for solution | Intravenous |
500 mg/5mL
|
| Injection, powder, lyophilized, for solution | Intravenous |
500 mg/1
|
| Injection, powder, lyophilized, for solution | Intravenous |
500 mg/100mL
|
| Injection, powder, lyophilized, for solution | Intravenous |
750 mg/15mL
|
| Injection, powder, lyophilized, for solution | Intravenous |
750 mg/1
|
| Injection, solution | Intravenous |
1 g/200mL
|
| Injection, solution | Intravenous |
1 g/1
|
| Injection, solution | Intravenous |
500 mg/1
|
| Injection, solution | Intravenous |
500 mg/100mL
|
| Injection, solution | Intravenous |
750 mg/150mL
|
| Injection, solution | Intravitreal |
1.25 g/250mL
|
| Injection, solution | Intravitreal |
1.50 g/300mL
|
| Powder | Not applicable |
1 g/1g
|
| Powder, for solution | Oral |
250 mg/5mL
|
| Solution | Oral |
250 mg/5mL
|
| Powder, for solution | Intravenous |
10 g / vial
|
| Injection, powder, for solution | — |
500 mg/1vial
|
| Injection, solution, concentrate | Intravenous |
500 mg/1vial
|
| Injection, powder, for solution | Intravenous |
50 mg/ml
|
| Injection, powder, lyophilized, for solution | Intravenous |
10 g/80mL
|
| Solution | Intravenous |
1000 mg / 200 mL
|
| Injection, powder, lyophilized, for solution | Intravenous |
500 mg
|
| Injection, powder, lyophilized, for solution | — |
500 mg
|
| Injection, powder, lyophilized, for solution | Intravenous |
1 g
|
| Injection, powder, lyophilized, for solution | Intravenous |
0.5 gr
|
| Injection, powder, lyophilized, for solution | Intravenous |
1 gr
|
| Injection, powder, for solution | Oral; Parenteral |
1 G
|
| Injection, powder, for solution | Oral; Parenteral |
500 MG
|
| Injection, powder, for solution | Intravenous |
|
| Capsule, coated | Oral |
12500000 mg
|
| Capsule, coated | Oral |
25000000 mg
|
| — | Intravenous |
1 gr
|
| — | Intravenous |
500 mg
|
| Injection, solution | Intravenous |
1000 mg
|
| Injection, solution | Intravenous |
500 mg
|
| Solution | Intravenous; Oral |
1 g
|
| Solution | Intravenous; Oral |
0.5 g
|
| Injection, powder, for solution | Intravenous |
100000000 mg
|
| Powder | Other |
10 mg
|
| Powder, for solution | Oral; Parenteral |
1000 MG
|
| Powder, for solution | Oral; Parenteral |
500 MG
|
| Injection, powder, for solution | Intravenous |
500 mg/1vial
|
| Powder | — |
500 mg/1vial
|